C-reactive protein, bone strength, and nine-year fracture risk: Data from the study of Women's Health Across the Nation (SWAN)

Journal of Bone and Mineral Research

Volumn 28, Issue 7, 2013, Pages 1688-1698

  Ishii, Shinya ^a   Cauley, Jane A ^b   Greendale, Gail A ^c   Crandall, Carolyn J ^c   Danielson, Michelle E ^b   Ouchi, Yasuyoshi ^a   Karlamangla, Arun S ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C REACTIVE PROTEIN; COMPOSITE STRENGTH INDICES OF FEMORAL NECK; FRACTURE; INFLAMMATION; OSTEOPOROSIS

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BODY MASS; BODY SIZE; BONE MINERAL; BONE STRENGTH; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FOLLOW UP; FRACTURE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MENOPAUSE; PHYSICAL ACTIVITY; SMOKING;

ABSORPTIOMETRY, PHOTON; ADULT; BODY WEIGHT; BONE DENSITY; C-REACTIVE PROTEIN; FEMALE; FEMORAL NECK FRACTURES; FOLLOW-UP STUDIES; HUMANS; LUMBOSACRAL REGION; MIDDLE AGED; MODELS, BIOLOGICAL; POSTMENOPAUSE; PREMENOPAUSE; SPINAL FRACTURES; UNITED STATES; WOMEN'S HEALTH;

EID: 84879195717     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1915     Document Type: Article

References (61)

1. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M., C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med. 2009; 151: 483-95.
2. Dehghan A, Kardys I, de Maat MP, Uitterlinden AG, Sijbrands EJ, Bootsma AH, Stijnen T, Hofman A, Schram MT, Witteman JC., Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes. 2007; 56: 872-8.
3. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F., Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol. 2005; 4: 371-80.
4. Hong T, Tan AG, Mitchell P, Wang JJ., A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration. Surv Ophthalmol. 2011; 56: 184-94.
5. Gough AK, Lilley J, Eyre S, Holder RL, Emery P., Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994; 344: 23-7.
6. Yee CS, Crabtree N, Skan J, Amft N, Bowman S, Situnayake D, Gordon C., Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis. 2005; 64: 111-3.
7. Bernstein CN, Leslie WD., Review article: osteoporosis and inflammatory bowel disease. Aliment Pharmacol Ther. 2004; 19: 941-52.
8. Graat-Verboom L, van den Borne BE, Smeenk FW, Spruit MA, Wouters EF., Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J Bone Miner Res. 2011; 26: 561-8.
9. Nakamura K, Saito T, Kobayashi R, Oshiki R, Oyama M, Nishiwaki T, Nashimoto M, Tsuchiya Y., C-reactive protein predicts incident fracture in community-dwelling elderly Japanese women: the Muramatsu study. Osteoporos Int. 2011; 22: 2145-50.
10. Cauley JA, Danielson ME, Boudreau RM, Forrest KY, Zmuda JM, Pahor M, Tylavsky FA, Cummings SR, Harris TB, Newman AB;, Health ABC Study. Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res. 2007; 22: 1088-95.
11. Pasco JA, Kotowicz MA, Henry MJ, Nicholson GC, Spilsbury HJ, Box JD, Schneider HG., High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA. 2006; 296: 1353-5.
12. Schett G, Kiechl S, Weger S, Pederiva A, Mayr A, Petrangeli M, Oberhollenzer F, Lorenzini R, Redlich K, Axmann R, Zwerina J, Willeit J., High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med. 2006; 166: 2495-501.
13. Barbour KE, Boudreau R, Danielson ME, Youk AO, Wactawski-Wende J, Greep NC, LaCroix AZ, Jackson RD, Wallace RB, Bauer DC, Allison MA, Cauley JA., Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. J Bone Miner Res. 2012; 27: 1167-76.
14. Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ 3rd, O'Neill T, Pols H, Reeve J, Silman A, Tenenhouse A., Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005; 20: 1185-94.
15. Ganesan K, Teklehaimanot S, Tran TH, Asuncion M, Norris K., Relationship of C-reactive protein and bone mineral density in community-dwelling elderly females. J Natl Med Assoc. 2005; 97: 329-33.
16. Koh JM, Khang YH, Jung CH, Bae S, Kim DJ, Chung YE, Kim GS., Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int. 2005; 16: 1263-71.
17. Kim BJ, Yu YM, Kim EN, Chung YE, Koh JM, Kim GS., Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women. Clin Endocrinol (Oxf). 2007; 67: 152-8.
18. Nguyen ND, Pongchaiyakul C, Center JR, Eisman JA, Nguyen TV., Identification of high-risk individuals for hip fracture: a 14-year prospective study. J Bone Miner Res. 2005; 20: 1921-8.
19. Waterloo S, Nguyen T, Ahmed LA, Center JR, Morseth B, Nguyen ND, Eisman JA, Søgaard AJ, Emaus N., Important risk factors and attributable risk of vertebral fractures in the population-based Tromso study. BMC Musculoskelet Disord. 2012; 13: 163.
20. Faulkner KG, Cummings SR, Black D, Palermo L, Glüer CC, Genant HK., Simple measurement of femoral geometry predicts hip fracture: the study of osteoporotic fractures. J Bone Miner Res. 1993; 8: 1211-127.
21. Alonso CG, Curiel MD, Carranza FH, Cano RP, Peréz AD., Femoral bone mineral density, neck-shaft angle and mean femoral neck width as predictors of hip fracture in men and women. Multicenter Project for Research in Osteoporosis. Osteoporos Int. 2000; 11: 714-20.
22. Beck TJ, Petit MA, Wu G, LeBoff MS, Cauley JA, Chen Z., Does obesity really make the femur stronger? BMD, geometry, and fracture incidence in the women's health initiative-observational study. J Bone Miner Res. 2009; 24: 1369-79.
23. Karlamangla AS, Barrett-Connor E, Young J, Greendale GA., Hip fracture risk assessment using composite indices of femoral neck strength: the Rancho Bernardo study. Osteoporos Int. 2004; 15: 62-70.
24. Yu N, Liu YJ, Pei Y, Zhang L, Lei S, Kothari NR, Li DY, Papasian CJ, Hamilton J, Cai JQ, Deng HW., Evaluation of compressive strength index of the femoral neck in Caucasians and chinese. Calcif Tissue Int. 2010; 87: 324-32.
25. Knapen MH, Schurgers LJ, Vermeer C., Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int. 2007; 18: 963-72.
26. Baptista F, Varela A, Sardinha LB., Bone mineral mass in males and females with and without Down syndrome. Osteoporos Int. 2005; 16: 380-8.
27. Xu XH, Xiong DH, Liu XG, Guo Y, Chen Y, Zhao J, Recker RR, Deng HW., Association analyses of vitamin D-binding protein gene with compression strength index variation in Caucasian nuclear families. Osteoporos Int. 2009; 21: 99-107.
28. Dong SS, Liu XG, Chen Y, Guo Y, Wang L, Zhao J, Xiong DH, Xu XH, Recker RR, Deng HW., Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. Calcif Tissue Int. 2009; 85: 104-12.
29. Cauley JA., Defining ethnic and racial differences in osteoporosis and fragility fractures. Clin Orthop Relat Res. 2011; 469: 1891-9.
30. Ishii S, Cauley JA, Greendale GA, Danielson ME, Safaei Nili N, Karlamangla A., Ethnic differences in composite indices of femoral neck strength. Osteoporos Int. 2012; 23: 1381-90.
31. Ishii S, Greendale GA, Cauley JA, Crandall CJ, Huang MH, Danielson ME, Karlamangla AS., Fracture risk assessment without race/ethnicity information. J Clin Endocrinol Metab. 2012; 97: 3593-602.
32. Vestergaard P., Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int. 2007; 18: 427-44.
33. Ishii S, Cauley JA, Crandall CJ, Srikanthan P, Greendale GA, Huang MH, Danielson ME, Karlamangla AS., Diabetes and femoral neck strength: findings from the Hip Strength Across the Menopausal Transition Study. J Clin Endocrinol Metab. 2012; 97: 190-7.
34. Sowers MF, Crawford S, Sternfeld B, Morganstein D, Gold EB, Greendale G, Evans D, Neer R, Matthews K, Sherman S, Lo A, Weiss G, Kelsey J., Design, survey, sampling and recruitment methods of SWAN: a multi-center, multi-ethnic, community based cohort study of women and the menopausal transition. In:, Lobo RA, Kelsey J, Marcus R, editors. Menopause: biology and pathobiology. San Diego: Academic Press; p. 175-88. 2000.
35. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, Sutton-Tyrrell K., Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?. J Am Coll Cardiol. 2009; 54: 2366-73.
36. Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MR, Sternfeld B, Pasternak RC, Chae CU;, SWAN Investigators. Ethnic differences in C-reactive protein concentrations. Clin Chem. 2008; 54: 1027-37.
37. Seeley DG, Browner WS, Nevitt MC, Genant HK, Scott JC, Cummings SR., Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1991; 115: 837-42.
38. Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner WS, Nevitt MC, Cummings SR;, Osteoporotic Fractures Research Group. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res. 2003; 18: 1947-54.
39. Baecke JA, Burema J, Frijters JE., A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982; 36: 936-42.
40. Ishii S, Karlamangla AS, Bote M, Irwin MR, Jacobs DR Jr, Cho HJ, Seeman TE., Gender, obesity and repeated elevation of C-reactive protein: data from the CARDIA cohort. PLoS One. 2012; 7: e36062.
41. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB., Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999; 282: 2131-5.
42. Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Gallimore JR, Pepys MB, Campbell LV., Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation. 2004; 109: 3022-8.
43. Schisterman EF, Cole SR, Platt RW., Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009; 20: 488-95.
44. Khera A, Vega GL, Das SR, Ayers C, McGuire DK, Grundy SM, de Lemos JA., Sex differences in the relationship between C-reactive protein and body fat. J Clin Endocrinol Metab. 2009; 94: 3251-8.
45. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE., The analysis of failure times in the presence of competing risks. Biometrics. 1978; 34: 541-54.
46. Graham JW., Missing data analysis: making it work in the real world. Annu Rev Psychol. 2009; 60: 549-76.
47. Redlich K, Smolen JS., Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov. 2012; 11: 234-50.
48. Mundy GR., Osteoporosis and inflammation. Nutr Rev. 2007; 65: S147-51.
49. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G., Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab. 2008; 93: 1952-8.
50. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr., Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112: 1796-808.
51. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM., Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995; 95: 2409-15.
52. Wellen KE, Hotamisligil GS., Inflammation, stress, and diabetes. J Clin Invest. 2005; 115: 1111-9.
53. Ehrlich PJ, Lanyon LE., Mechanical strain and bone cell function: a review. Osteoporos Int. 2002; 13: 688-700.
54. Bonewald LF, Johnson ML., Osteocytes, mechanosensing and Wnt signaling. Bone. 2008; 42: 606-15.
55. Li GW, Chang SX, Xu Z, Chen Y, Bao H, Shi X., Prediction of hip osteoporotic fractures from composite indices of femoral neck strength. Skeletal Radiol. 2012; 42: 195-201.
56. Faulkner KG, Wacker WK, Barden HS, Simonelli C, Burke PK, Ragi S, Del Rio L., Femur strength index predicts hip fracture independent of bone density and hip axis length. Osteoporos Int. 2006; 17: 593-9.
57. Orwoll ES, Marshall LM, Nielson CM, Cummings SR, Lapidus J, Cauley JA, Ensrud K, Lane N, Hoffmann PR, Kopperdahl DL, Keaveny TM;, Osteoporotic Fractures in Men Study Group. Finite element analysis of the proximal femur and hip fracture risk in older men. J Bone Miner Res. 2009; 24: 475-83.
58. Leslie WD, Pahlavan PS, Tsang JF, Lix LM., Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort. Osteoporos Int. 2009; 20: 1767-74.
59. Riggs BL, Melton LJ, Robb RA, Camp JJ, Atkinson EJ, McDaniel L, Amin S, Rouleau PA, Khosla S., A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res. 2008; 23: 205-14.
60. Follet H, Boivin G, Rumelhart C, Meunier PJ., The degree of mineralization is a determinant of bone strength: a study on human calcanei. Bone. 2004; 34: 783-9.
61. Beck TJ., Extending DXA beyond bone mineral density: understanding hip structure analysis. Curr Osteoporos Rep. 2007; 5: 49-55.